Submit an Article
Navigate
Home
Editorial Board
Editorial Policies
Current Volume
Archive
Scientific Integrity
Publication Ethics Statements
Interviews with Outstanding Authors
Newsroom
Sponsored Conferences
Podcast
Contact
Special Collections
Submit an Article
Online ISSN: 1945-4589
Research Paper
|
Volume 15, Issue 11
|
pp. 4926–4948
The potential of FCRL genes as targets for cancer treatment: insights from bioinformatics and immunology
Back to article
Figure 6
(6 of 11)
−
100%
+
Figure 6.
GESA for DEGs of high- and low-FCRL1 group in different cancer types.
(
A
) BRCA, (
B
) CESC, (
C
) HNSC, (
D
) LIHC, (
E
) LUAD, (
F
) READ, (
G
) SARC, (
H
) SKCM.
